No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MEDP240719C420000
- 14.70
- +0.95+6.91%
15min DelayClose Jun 28 15:59 ET
14.70High14.70Low
14.70Open13.75Pre Close1 Volume20 Open Interest420.00Strike Price1.47KTurnover24.77%IV5.55%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier19DDays to Expiry14.70Extrinsic Value100Contract SizeAmericanOptions Type0.3972Delta0.0162Gamma63.36Leverage Ratio-0.2562Theta0.0855Rho25.17Eff Leverage0.3706Vega
Intraday
- 5D
- Daily
News
Peering Into Medpace Hldgs's Recent Short Interest
Medpace Hldgs's (NYSE:MEDP) short percent of float has fallen 8.61% since its last report. The company recently reported that it has 854 thousand shares sold short, which is 4.14% of all regular share
Medpace Holdings, Inc. to Report Second Quarter 2024 Financial Results on July 22, 2024
CINCINNATI--(BUSINESS WIRE)--Jun. 26, 2024-- Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its second quarter 2024 financial results after the market close on M
An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
In this article we are going to estimate the intrinsic value of Medpace Holdings, Inc. (NASDAQ:MEDP) by taking the expected future cash flows and discounting them to their present value.
Here's How Much You Would Have Made Owning Medpace Hldgs Stock In The Last 5 Years
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 32.97% on an annualized basis producing an average annual return of 46.08%. Currently, Medpace Hldgs has a market capit
Express News | Medpace Holdings Inc : Baird Raises Target Price to $456 From $454
Medpace Holdings (MEDP) Continues to Deliver Robust Financial Results
Comments
Investors expect Medpace Holdings to outperform the market, hence its high P/E ratio. Strong future growth anticipation makes investors pay more for the stock, supporting the share price.
The Price Is Right For Medpace Holdings, Inc. (NASDAQ:MEDP) 1
Medpace Holdings' robust conversion of profit to free cash flow is promising. Its underlying earnings potential may even surpass the statutory profit. Its earnings per share have seen a remarkable growth over the past three years.
1
Medpace Holdings' market sentiment remains steady, mirroring EPS growth. The stock's recent performance shows improvement, with a 90% shareholder return over the last year, surpassing the five-year TSR of 41% per year. The strong share price momentum suggests a closer look at the stock may be worthwhile.
Medpace's high P/E is backed by its forecast growth being higher than the wider market. Investors are quite confident in the company's future earnings and seem willing to pay more for the stock, suggesting a bullish outlook.
Insider selling at current price (US$274) is less worrying, but there were no purchases over the past year to boost confidence. A high level of insider ownership often implies interests of all shareholders are considered, though recent history of share sales triggers some hesitation.
Read more